$BSX Up to date company activities and other important

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
$BSX Up to date company activities and other important information about $BSX

$BSX

DD Notes ~ http://www.ddnotesmaker.com/BSX

##### recent news/filings ~ source: finance.yahoo.com

Fri, 23 May 2014 22:30:09 GMT ~ Why Bayer Sold This Division to Boston Scientific
read full: http://www.fool.com/investing/general/2014/05...lnk0000001
*********************************************************

Thu, 22 May 2014 18:22:02 GMT ~ Good News at Boston Scientific: What's Next
read full: http://www.fool.com/investing/general/2014/05...lnk0000001
*********************************************************

Wed, 21 May 2014 15:24:37 GMT ~ Boston Scientific management to meet with Piper Jaffray
read full: http://www.theflyonthewall.com/permalinks/ent...er-Jaffray
*********************************************************

Wed, 21 May 2014 13:14:00 GMT ~ Boston Scientific Lotus™ Valve System Demonstrates Strong Performance And Safety Profile At Six Months
- PARIS, May 21, 2014 /PRNewswire/ -- Further validating its advanced transcatheter aortic valve implantation (TAVI) technology, the Boston Scientific Corporation (BSX) Lotus™ Valve System continued to demonstrate impressive performance at six months, according to new data presented at EuroPCR 2014 in Paris. Results from the REPRISE II clinical trial demonstrated that the Lotus Valve System delivered sustained safety and effectiveness outcomes out to six months, with only 1.1 percent of patients having moderate paravalvular aortic regurgitation (leaking). No severe cases occurred. The data were presented by Professor Ian Meredith, director of MonashHeart, at Monash Medical Centre in Melbourne, Australia, and principal investigator of the REPRISE II trial. The study is evaluating the Lotus Valve System in symptomatic patients with severe aortic valve stenosis considered at high risk for surgical valve replacement. The primary device performance endpoint of 30-day mean aortic valve pressure gradient, as assessed by an independent core lab, was met as the 30-day mean aortic valve pressure gradient of 11.5 +/- 5.2mmHg was significantly less than the performance goal of 18 mmHg (P<0.001). At six months, the mean aortic valve pressure gradient remained low and stable at 11.4 +/- 4.6 mmHg.
read full: http://finance.yahoo.com/news/boston-scientif...00635.html
*********************************************************

Wed, 21 May 2014 12:05:34 GMT ~ Boston Scientific's Synergy stent system reports strong performance data
read full: http://www.theflyonthewall.com/permalinks/ent...mance-data
*********************************************************

##### chart ~ source: stockcharts.com

stockcharts.com/c-sc/sc?s=BSX&p=D&b=5&g=0&id=p95448242713

##### chart ~ source: eoddata.com

http://chart.eoddata.com/?e=OTCBB&s=BSX&a...D&b=BB

##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/BSX/company-info
Ticker: $BSX
OTC Market Place: Not Available
CIK code: 0000885725
Company name: Boston Scientific Corp.
Company website: http://www.bsci.com
Incorporated In: DE, USA

##### extra dd links

Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/BSX/filings
Latest financials: http://www.otcmarkets.com/stock/BSX/financials
Latest news: http://www.otcmarkets.com/stock/BSX/news - http://finance.yahoo.com/q/h?s=BSX+Headlines

Major holdings: http://data.cnbc.com/quotes/BSX/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=BSX+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/BSX.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=BSX

RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search

DTCC: http://search2.dtcc.com/?q=Boston+Scientific+...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...tific+Corp.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.bsci.com
Alexa: http://www.alexa.com/siteinfo/http://www.bsci.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.bsci.com

Short Sales: http://www.otcmarkets.com/stock/BSX/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/BSX/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/BSX/research
Historical Prices: http://finance.yahoo.com/q/hp?s=BSX+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=BSX+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=BSX+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=BSX+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=BSX+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=BSX+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=BSX
Balance Sheet: http://finance.yahoo.com/q/bs?s=BSX
Cash Flow: http://finance.yahoo.com/q/cf?s=BSX+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/BSX
Bloomberg: http://www.bloomberg.com/quote/BSX:US
Morningstar: http://quotes.morningstar.com/stock/s?t=BSX
Bussinessweek: http://investing.businessweek.com/research/st...ticker=BSX
Barchart: http://www.barchart.com/quotes/stocks/BSX
OTC Short Report: http://otcshortreport.com/index.php?index=BSX
Investopedia: http://www.investopedia.com/markets/stocks/BSX/?wa=0

http://www.pennystocktweets.com/stocks/profile/BSX

##### last known share structure ~ source: otcmarkets.com

Market Value: $17,128,649,447 a/o May 27, 2014
Shares Outstanding: 1,322,675,633 a/o Apr 30, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01

##### business description ~ source: otcmarkets.com



DD Notes ~ http://www.ddnotesmaker.com/BSX

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 4

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 8

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 3

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 2

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 2

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 6

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 5

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 9

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading

Top 5 Most Recently Viewed Articles

BlackRock's Strong Performance Lifts Market Spirits

Updated Category News Views 62

BlackRock's Earnings Impact Future Market Trends As investors eagerly glance at the market, recent trends suggest a positive shift, particularly with BlackRock, Inc. reporting remarkable third-quarter earnings. The upbeat results have lifted not only the company’s profile but also the sentiments across various sectors. Market Overview In recent trading sessions, U.S....

Continue Reading
Endo Unveils I Got Somebody Campaign for Peyronie's Disease

Updated Category News Views 648

Endo Launches Awareness Campaign for Peyronie’s Disease Endo, Inc. (OTCQX: NDOI) has recently introduced a compelling initiative titled I Got Somebody. This campaign is designed to encourage men to confront their feelings of embarrassment around Peyronie's disease (PD) and to have open discussions about this condition which affects many. The company aims to empower men...

Continue Reading
Investigation Launched into Aehr Test Systems for Investors' Losses

Updated Category News Views 218

Investigation into Aehr Test Systems, Inc. Focused on Investor Protection The Law Offices of Frank R. Cruz are actively investigating Aehr Test Systems, Inc. (NASDAQ: AEHR) in light of significant concerns raised regarding the company’s adherence to federal securities laws. This investigation comes as a response to alarming financial disclosures made public by the...

Continue Reading
SeaStar Medical Advances adult AKI Treatment with Stanford

Updated Category News Views 69

SeaStar Medical Welcomes Stanford Medicine's Enrollment in AKI Trial SeaStar Medical Holding Corporation (NASDAQ: ICU) is excited to announce that Stanford Medicine will begin actively enrolling subjects in its pivotal trial focused on Adult Acute Kidney Injury (AKI). This collaboration emphasizes the company’s mission to enhance treatment options for patients...

Continue Reading
Exciting Updates on Class A Shares for Investors and Stakeholders

Updated Category News Views 163

Important Distribution Announcement for Class A Shareholders In a recent announcement, Real Estate Split Corp. (TSX: RS) has excitedly shared plans to distribute dividends to Class A shareholders. This distribution not only signifies growth but also represents the company's commitment to providing value to its investors. Key Dates for the Upcoming Distribution For...

Continue Reading